pipeline, page-9

Another paper thin hint that this deal could fall into place.

We know that Lovenox is going to be used with Unifill. Sanofi meet the majority of their global supply of Lovenox from their Le Trait, Fance site. Digging a little deeper and the same site has been nominated as the launch site for Alirocumab.

So that means the site will most likely have completed and validated any filling line changes required for Lovenox in Unifill. From handling the borosilicate glass through to labelling the syringes etc etc.

So filling Alirocumab into Unifill and then using clubbing it together with the Lisa Auto Injector...another piece of the puzzle.